about
O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetesTestosterone and vascular function in agingO-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathwayEthanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in ratsMurine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide SymposiumImpaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylationDownregulation of Nuclear Factor Erythroid 2-Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in HypertensionReactive oxygen species: players in the cardiovascular effects of testosteroneEnalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats.Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties.Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction.Vascular O-GlcNAcylation augments reactivity to constrictor stimuli by prolonging phosphorylated levels of the myosin light chain.p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated miceThe involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes.Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation.Female sexual dysfunction: therapeutic options and experimental challenges.An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue.Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1Mitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice.Diacylglycerol Kinase Inhibition and Vascular FunctionArginase II deletion increases corpora cavernosa relaxation in diabetic mice.Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats.Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activationUridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.Effects of estrogen on the vascular system.The role of uridine adenosine tetraphosphate in the vascular system.Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta.Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.
P50
Q27693206-358EBF7E-81BB-42CA-AA58-CDF8F4FE5E02Q28081462-5DC7E6E8-09F5-4E4B-9A72-0CAD8ADD3F61Q28383213-94C71400-655F-4D60-B41B-5E6E2FEE051DQ28571140-9EAB5E9C-82F7-4497-AD16-0AF1DFEFDB04Q28571631-91D599FA-39CE-4814-92DB-DB8D5BC48F17Q28574132-EDF96C2C-B241-4EAB-BB78-CE758EB42CE8Q28581177-3B7E3D29-41D6-4EC9-B1E4-9CE26CCCFD21Q28581557-D8154008-BEF0-46AA-A89F-02F1546DB794Q28602465-FE8E605B-E7B5-4E02-A9B1-B09A543C76FCQ30273565-A8C6749F-1875-44ED-8051-38052A7A403BQ33572366-612C970B-9CEC-4CD9-B366-A406BC9F8626Q33599905-17766C1C-197A-4F37-8458-B94420C73063Q33748607-2F1F3D95-5F64-4E5C-82EA-FC062671E355Q34073718-BB59EEF6-0C24-453C-BD09-33338E32A3E2Q34272394-8CA98966-D654-46F3-8F4C-C1C016D2DEF4Q34376157-DC86CB29-6B82-4196-A517-02EC9D26B84CQ34409899-312A7B3D-6DA6-44F7-9689-7C410638B8B6Q34412164-A150AF85-E14B-4FDD-B7D4-AACCEF08134EQ34433634-7DB32F43-8451-4476-97DE-C07182578AF5Q34450221-26A322A6-058E-4D27-A6B2-078D1302E897Q34469704-82FAF883-C7A6-42B8-95E6-24D1D129BB3BQ34498189-CFA9B064-428E-4C94-BCAA-851AFC13C478Q34548150-D71A0EE6-E393-48B0-815D-CBFEA4F31450Q34598611-824C64D5-2800-45C5-83BB-F18349C48B23Q34622646-59890720-5582-49FA-9182-A8ECF0ADB946Q34700791-04C00835-E45D-431E-8B3A-FEA8F08E9271Q34705086-38C90D9B-61FA-4340-B7DC-8D757D2EA509Q34718182-690594FB-C20F-43F6-AEFD-00C074CE4FC1Q34780141-72700DC1-A900-414E-9B8A-158B2EB951F9Q34899768-323342D4-F92C-43AE-A7AA-B7E7B0DECD58Q34914993-D9306E7D-7263-4073-BC45-59BEBA953B5BQ35050926-D63294E1-E346-4E55-A1F9-B2EF0FF59C31Q35123162-2801821E-8622-4BF5-B3FC-8AA93465A9B7Q35135440-CDF0B9C8-069D-4D2E-B133-5AB5560BE81AQ35159887-FCE181AA-DD2B-4840-8194-2A9CE0F12E76Q35205898-3BF69D01-10F2-4B33-9677-8CDB58A2DDC4Q35504071-D3B36E46-D8F9-4BD2-8C99-B6908A8FD8DDQ35529294-3A423FCB-124B-4AB0-B621-A04A637AE1E7Q35599981-AA5D7F16-660F-459C-AC6B-A7577AC57AADQ36056243-941C9960-6EB0-40F6-8D4F-AC933319FF4B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rita C. Tostes
@ast
Rita C. Tostes
@en
Rita C. Tostes
@es
Rita C. Tostes
@nl
Rita C. Tostes
@sl
type
label
Rita C. Tostes
@ast
Rita C. Tostes
@en
Rita C. Tostes
@es
Rita C. Tostes
@nl
Rita C. Tostes
@sl
prefLabel
Rita C. Tostes
@ast
Rita C. Tostes
@en
Rita C. Tostes
@es
Rita C. Tostes
@nl
Rita C. Tostes
@sl
P106
P1153
7003428812
P21
P31
P496
0000-0002-9446-0707